Lifecore Biomedical (LFCR) Cash from Financing (Quarterly): -0.852M

Lifecore Biomedical, Inc. (LFCR)

6.445 -0.08 (-1.15%) USD | NASDAQ | Oct 06, 16:00

6.45 0.00 (0.00%) After-Hours: 18:50

Cash from Financing (Quarterly) Chart

Historical Cash from Financing (Quarterly) Data

View and export this data back to 1998. Start Trial.

Date	Value
June 30, 2026	-0.852M
March 31, 2026	-0.256M
December 31, 2025
September 30, 2025
May 31, 2025	-0.402M
February 28, 2025	-6.782M
November 30, 2024	12.52M
August 31, 2024	1.093M
May 31, 2024	-0.738M
February 29, 2024	7.761M
November 30, 2023	-2.448M
August 31, 2023	2.934M
May 31, 2023	20.90M
February 28, 2023	6.083M
November 30, 2022	8.809M
August 31, 2022	3.906M
May 31, 2022	19.14M
February 28, 2022	-47.09M
November 30, 2021	9.746M
August 31, 2021	-38.82M
May 31, 2021	-2.627M
February 28, 2021	19.97M
November 30, 2020	-4.247M
August 31, 2020	-16.51M
May 31, 2020	15.02M

Date	Value
February 29, 2020	-6.077M
November 30, 2019	15.06M
August 31, 2019	16.02M
May 31, 2019	5.211M
February 28, 2019	61.60M
November 30, 2018	1.491M
August 31, 2018	10.72M
May 31, 2018	12.70M
February 28, 2018	0.60M
November 30, 2017	-1.999M
August 31, 2017	6.201M
May 31, 2017	2.126M
February 28, 2017	-2.796M
November 30, 2016	-2.352M
August 31, 2016	-5.613M
May 31, 2016	1.148M
February 29, 2016	9.302M
November 30, 2015	7.407M
August 31, 2015	-1.789M
May 31, 2015	-7.187M
February 28, 2015	2.844M
November 30, 2014	7.071M
August 31, 2014	5.441M
May 31, 2014	-1.261M
February 28, 2014	0.191M

Cash From Financing Definition

Represents the net cash flow resulting from the company's financing activities. Financing activities represent movement in the company's debt and share capital and other activities.

Read full definition.

Cash from Financing (Quarterly) Range, Past 5 Years

View Cash from Financing (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

Cash from Financing (Quarterly) Benchmarks

View Cash from Financing (Quarterly) Benchmarks